It’s time to take psilocybin seriously as a possible treatment for substance use disorders. August 24, 2016
It's time to take psilocybin seriously as a possible treatment for substance use disorders. August 24, 2016
The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT1A, D2 and TAAR1 receptors August 17, 2016
Urinary and plasma oxytocin changes in response to MDMA or intranasal oxytocin administration August 16, 2016
